To the best of our knowledge, this is the first study to describe possible interactions between muscle resident FAPs and engrafted cells to illustrate the therapeutic potential of IL4 in combination with cell therapy for DMD. This evidence concerns the gene IL4 and Duchenne muscular dystrophy.